Article
Novel K540N mutation in Plasmodium falciparum dihydropteroate synthetase confers a lower level of sulfa drug resistance than does a K540E mutation.
Antimicrobial agents and chemotherapy - 1 May 2011
Lumb Vanshika, Sharma Yagya D
Abstract excerpt
Sulfadoxine (SDX) and sulfamethoxazole (SMX) each inhibit the Plasmodium falciparum dihydropteroate synthetase (PfDHPS), and certain point mutations in this enzyme yield the drug-resistant parasite. Using a simple Escherichia coli model system, we describe here the effect of the recently reported novel K540N mutation in PfDHPS on the level of SDX/SMX resistance. The survival rate of the transformed E. coli...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
